N/A
N=30
Virtual Reality Experience in First Trimester D&C
First Trimester Abortion · Virtual Reality
Bottom Line
View on ClinicalTrials.gov: NCT03533036 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Number of Participants Able to Use VR Device Throughout the Entire Duration of First Trimester Surgical Abortion. — 6 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- applied VR headset (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of California, Los Angeles
- Primary completion
- Sep 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Able to Use VR Device Throughout the Entire Duration of First Trimester Surgical Abortion. |
6 | — |
| SECONDARY Change in Procedure Related Anxiety as Assessed by the Visual Analog Scale (VAS). |
-3.97; -2.71 | — |
Summary
Virtual reality (VR) has been used in health care settings to decrease anxiety and pain. This project is a feasibility study to evaluate whether virtual reality can be used in the setting of a first trimester pregnancy termination by D&C and whether the use of virtual reality (VR) headsets can help decrease anxiety for patients during this procedure.
Eligibility Criteria
Inclusion Criteria
- Age 18 or over
- Elective surgical abortion under local anesthesia
- English speaker
Exclusion Criteria
- No psychiatric history
- No history of motion sickness or vertigo
- No history of seizures or epilepsy
- No recent eye surgery or visual impairment
- No claustrophobia.
- No current nausea or vomiting
- Not on seizure-threshold lowering medications
Data sourced from ClinicalTrials.gov (NCT03533036). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.